Caas Capital Management LP Tenaya Therapeutics, Inc. Transaction History

Caas Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$18.41 - $29.58 $920,500 - $1.48 Million	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.35 - $26.66 $767,500 - $1.33 Million	50,000 New	50,000 $1.03 Million

56.4M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $51.7M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.